News

April 28, 2026

International Endovascular Corporation (IEVC) Acquires DABRA™ Laser System to Advance Treatment of Peripheral Artery Disease

IEVC has acquired the DABRA™ Laser System and related assets from Catheter Precision, positioning the company to reintroduce this clinically proven excimer laser technology for the treatment of peripheral artery disease (PAD). The acquisition marks a key step in IEVC’s strategy to advance innovative vascular therapies and expand future clinical applications.

May 5, 2024

International Endovascular Corporation (IEVC) Launches to Advance Next-Generation Vascular Technologies

IEVC was founded to identify, acquire, and advance differentiated medical device technologies for the treatment of vascular disease. Operated by CyMeda, Inc., the company combines deep expertise in laser-based therapies with a capital-efficient operating model designed for focused development and strategic execution.